• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?

作者信息

McVary Kevin T

出版信息

Eur Urol. 2006 Dec;50(6):1153-6. doi: 10.1016/j.eururo.2006.09.014. Epub 2006 Sep 29.

DOI:10.1016/j.eururo.2006.09.014
PMID:17045387
Abstract
摘要

相似文献

1
Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?磷酸二酯酶调控后骨盆功能的意外见解——泌尿外科的下一步何去何从？
Eur Urol. 2006 Dec;50(6):1153-6. doi: 10.1016/j.eururo.2006.09.014. Epub 2006 Sep 29.
2
Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
Int J Impot Res. 2006 Nov-Dec;18(6):570-1; author reply 572-3. doi: 10.1038/sj.ijir.3901488. Epub 2006 Jul 20.
3
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction.旨在发现用于治疗勃起功能障碍的选择性磷酸二酯酶5抑制剂的多环鸟嘌呤衍生物的构效关系研究
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1291-4. doi: 10.1016/j.bmcl.2003.12.027.
4
Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?环磷酸鸟苷与磷酸二酯酶5抑制剂疗法：未来发展如何？
Mol Pharmacol. 2004 Jul;66(1):11-3. doi: 10.1124/mol.104.001388.
5
Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.喹啉作为极具效力和选择性的磷酸二酯酶5抑制剂，有望成为治疗勃起功能障碍的药物。
Bioorg Med Chem Lett. 2004 Mar 22;14(6):1577-80. doi: 10.1016/j.bmcl.2003.12.090.
6
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
BJU Int. 2006 Dec;98(6):1331-2. doi: 10.1111/j.1464-410X.2006.06628_5.x.
7
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.使用磷酸二酯酶-5抑制剂治疗良性前列腺增生和下尿路症状的临床前证据。
BJU Int. 2006 Dec;98(6):1259-63. doi: 10.1111/j.1464-410X.2006.06501.x. Epub 2006 Sep 6.
8
Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
Eur Urol. 2006 Jul;50(1):29-30. doi: 10.1016/j.eururo.2006.03.008. Epub 2006 Mar 20.
9
Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".勃起功能障碍男性中5型磷酸二酯酶抑制剂治疗的优化：将“无反应者”转变为“有反应者”
Eur Urol. 2006 Jul;50(1):31-3. doi: 10.1016/j.eururo.2005.12.005. Epub 2006 Jan 4.
10
This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.本文延续了阿达坎教授在勃起生理学经典药理学研究方面的卓越贡献。
Eur Urol. 2007 Jul;52(1):259-60.

引用本文的文献

1
The Role of 5-Phosphodiesterase Inhibitors (PDE-5I) in Current Benign Prostatic Hyperplasia Treatment: A Narrative Review.5-磷酸二酯酶抑制剂（PDE-5I）在当前良性前列腺增生治疗中的作用：叙述性综述。
Medicina (Kaunas). 2024 Oct 23;60(11):1736. doi: 10.3390/medicina60111736.
2
Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.他达拉非单药治疗慢性前列腺炎/慢性盆腔疼痛综合征：一项随机、双盲、安慰剂对照的临床研究。
World J Urol. 2022 Oct;40(10):2505-2511. doi: 10.1007/s00345-022-04074-4. Epub 2022 Jul 8.
3
Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective, randomized study.
他达拉非与坦索罗辛治疗良性前列腺增生继发下尿路症状的前瞻性随机研究。
Cent European J Urol. 2019;72(1):44-50. doi: 10.5173/ceju.2019.1570. Epub 2019 Mar 14.
4
Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options.睾酮对下尿路的影响超出前列腺：新见解，新治疗选择。
Arab J Urol. 2011 Jun;9(2):147-52. doi: 10.1016/j.aju.2011.06.003. Epub 2011 Sep 9.
5
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review.磷酸二酯酶-5抑制剂在前列腺炎症中的作用：综述
J Inflamm (Lond). 2015 Sep 15;12:54. doi: 10.1186/s12950-015-0099-7. eCollection 2015.
6
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.他达拉非在有和无勃起功能障碍的男性良性前列腺增生治疗中的应用综述。
Ther Adv Urol. 2014 Aug;6(4):135-47. doi: 10.1177/1756287214531639.
7
Lower urinary-tract symptoms and testosterone in elderly men.老年男性的下尿路症状与睾酮
World J Urol. 2008 Aug;26(4):359-64. doi: 10.1007/s00345-008-0284-x. Epub 2008 Jul 2.